secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-03-09T23:59:59+00:00
Accession:  0001618835-23-000014
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences CFO Justin J. File resigns; Albert Altro appointed interim CFO
--------------------------------------------------------------------------------

- Justin J. File resigned as CFO effective April 3, 2023, to pursue other opportunities; no disagreement with company.
- Albert Altro, with over 30 years of financial experience, appointed interim CFO on March 6, 2023.
- Altro compensated at $275-$450/hour via engagement with his firm Traverse LLC; $40,000 retainer paid.
- Company issued a press release on March 9, 2023, announcing the changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000014/0001618835-23-000014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000161883523000014/evfm-20230303.htm
  HTML page:      https://secwatch.observer/filing/0001618835-23-000014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer